Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: Comparison with nonmetastic Barrett's adenocarcinoma

Modern Pathology

Volumn 13, Issue 7, 2000, Pages 814-824

  Walch, Axel K ^a,c   Zitzelsberger, Horst F ^a,b   Bink, Karin ^c   Hutzler, Peter ^a   Bruch, Jochen ^a   Braselmann, Herbert ^a   Aubele, Michaela M ^a   Mueller, James ^d   Stein, Hubert ^d   Siewert, Jörg R ^d   Höfler, Heinz ^a   Werner, Martin ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Barrett's adenocarcinoma; Comparative genomic hybridization; Fluorescence in situ hybridization; Genetic heterogeneity; Metastasis

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHROMOSOME 17Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 3Q; CHROMOSOME 7P; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; ESOPHAGUS CARCINOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033941269     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880143     Document Type: Article

References (40)

1. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
2. Streitz JM Jr, Ellis FH Jr, Gibb SP, Balogh K, Watkins E Jr. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Annu Surg 1991;213:122-5.
3. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol 1995;19:183-91.
4. Menke-Pluymers MB, van Drunen E, Vissers KJ, Mulder AH, Tilanus HW, Hagemeijer A. Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet 1996;90:109-17.
5. Persons DL, Croughan WS, Borelli KA, Cherian R. Interphase cytogenetics esophageal adenocarcinoma and precursor lesions. Cancer Genet Cytogenet 1998;106:11-7.
6. Moskaluk CA, Hu J, Perlman EJ. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer 1998;22:305-11.
7. El-Rifai W, Harper JC, Cummings OW, Hyytinen ER, Frierson HF Jr, Knuutila S, et al. Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res 1998;58:34-7.
8. van Dekken H, Geelen E, Dinjens WN, Wijnhoven BP, Tilanus HW, Tanke HJ, et al. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res 1999;59: 748-52.
9. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SEH. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Genes Chromosomes Cancer 1998;21:49-60.
10. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 1996;12:1873-8.
11. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ. Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 1996;56:4499-502.
12. van Dekken H, Vissers CJ, Tilanus HW, Tanke HJ, Rosenberg C. Clonal analysis of a case of multifocal esophageal (Barrett's) adenocarcinoma by comparative genomic hybridization. J Pathol 1999;188:263-6.
13. Hermanek P, Wittekind, LH. Classification of malignant tumors. Berlin: Springer-Verlag; 1997.
14. Zitzelsberger H, Kulka U, Lehmann E, Walch A, Smida J, Aubele M, et al. Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization. Virchows Arch 1998;433:297-304.
15. Weber RG, Scheer M, Born IA, Joos S, Cobbers JM, Hofele C, et al. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 1998;153:295-303.
16. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998;58:4721-7.
17. Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 1998;153:1089-98.
18. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, et al. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 1999;110: 94-102.
19. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994;10:231-43.
20. Hopman AH, Ramaekers FC, Raap AK, Beck JL, Devilee P, van der Ploeg M, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988;89:307-16.
21. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, Testa JR. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 1997;57:2116-20.
22. Volinia S, Hiles I, Ormondroyd E, Nizetic D, Antonacci R, Rocchi M, et al. Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110-alpha (PIK3CA) gene. Genomics 1994;24: 472-7.
23. Herrington CS, Leek RD, McGee JO. Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes. J Pathol 1995;176:353-9.
24. Terada R, Yasutake T, Yamaguchi E, Hisamatsu T, Nakamura S, Ayabe H, et al. Higher frequencies of numerical aberrations of chromosome 17 in primary gastric cancers are associated with lymph node metastasis. J Gastroenterol 1999; 34:11-7.
25. Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res 1989;49:6605-9.
26. Tahara E. Molecular biology of gastric cancer. World J Surg 1995;19:484-8; discussion 489-90.
27. Margolis B, Silvennoinen O, Comoglio F, Roonprapunt C, Skolnik E, Ullrich A, et al. High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc Natl Acad Sci U S A 1992;89: 8894-8.
28. Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, et al. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J 1994;13:1331-40.
29. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, et al. A novel variant of human Grb7 is associated with invasive esophageal carcinoma. J Clin Invest 1998;102:821-7.
30. Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998; 23:307-16.
31. Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nordling S, et al. 17ql2-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 1997;20:38-43.
32. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 1996;12:1565-9.
33. Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol 1995; 48:129-32.
34. al-Kasspooles M, Moore JH, Orringer MB, Beer DG. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 1993; 54:213-9.
35. Yoshida K, Tsuda T, Matsumura T, Tsujino T, Hattori T, Ito H, et al. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57:285-90.
36. Yin XY, Donovan-Peluso M, Whiteside TL, Johnson JT, Day R, Herberman RB, et al. Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 1991;3:443-54.
37. Daly RJ, Sanderson GM, Janes PW, Sutherland RL. Cloning and characterization of GRB14, a novel member of the GRB7 gene family. J Biol Chem 1996;271:12502-10.
38. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
39. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999;22:106-9.
40. Walch A, Zitzelsberger H, Bruch J, Keller G, Angermeier D, Aubeie M, et al. Chromosomal imbalances in Barrett's adenocarcinoma and in the metaplasia-dysplasia-carcinoma sequence. Am J Pathol 2000;156:555-66.